Eltenac

CAS: 72895-88-6

Ref. 3D-FE22656

Produktinformation

• Name: Eltenac
• Synonyme: 4-[(2,6-Dichlorophenyl)amino]-3-thiopheneacetic acid4-(2,6-Dichloroanilino)-3-thiopheneacetic acidTelzenac
• Marke: Biosynth
• Beschreibung: Eltenac is a nonsteroidal anti-inflammatory drug with a carbonyl group. It has been shown to be effective in the treatment of diabetic patients who have a body mass index between 25 and 30. Eltenac has been shown to reduce median plasma fibrinogen levels, which may be due to its alkalizing effect on the stomach. The clinical relevance of this effect is not known. Eltenac inhibits prostaglandin biosynthesis by competing with cyclooxygenase for the common substrate arachidonic acid, which leads to decreased production of prostaglandins and an anti-inflammatory effect. This drug also has long-term efficacy, as it can take up to six months for blood concentrations of eltenac to decline after discontinuation.

Chemische Eigenschaften

• Molekulargewicht: 302.18 g/mol
• Formel: C₁₂H₉Cl₂NO₂S
• Reinheit: Min. 98 Area-%
• Farbe/Form: Powder
• InChl: InChI=1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17)
• InChI Key: InChIKey=AELILMBZWCGOSB-UHFFFAOYSA-N
• SMILES: O=C(O)Cc1cscc1Nc1c(Cl)cccc1Cl